Holcombe E. Grier

18.9k total citations · 4 hit papers
145 papers, 11.7k citations indexed

About

Holcombe E. Grier is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Neurology. According to data from OpenAlex, Holcombe E. Grier has authored 145 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Pulmonary and Respiratory Medicine, 48 papers in Surgery and 37 papers in Neurology. Recurrent topics in Holcombe E. Grier's work include Sarcoma Diagnosis and Treatment (76 papers), Neuroblastoma Research and Treatments (34 papers) and Testicular diseases and treatments (18 papers). Holcombe E. Grier is often cited by papers focused on Sarcoma Diagnosis and Treatment (76 papers), Neuroblastoma Research and Treatments (34 papers) and Testicular diseases and treatments (18 papers). Holcombe E. Grier collaborates with scholars based in United States, Canada and Switzerland. Holcombe E. Grier's co-authors include Jane C. Weeks, Joanne Wolfe, Mark Krailo, Mark C. Gebhardt, Jennifer W. Mack, Antonio R. Pérez‐Atayde, Michael P. Link, Paul A. Meyers, Paul S. Dickman and Susanne Salem‐Schatz and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Holcombe E. Grier

144 papers receiving 11.4k citations

Hit Papers

Addition of Ifosfamide an... 2000 2026 2008 2017 2003 2000 2008 2012 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Holcombe E. Grier 5.7k 3.0k 2.5k 2.4k 2.1k 145 11.7k
Neyssa Marina 3.6k 0.6× 3.5k 1.2× 2.1k 0.9× 2.2k 0.9× 848 0.4× 160 9.8k
Michael P. Link 4.5k 0.8× 1.3k 0.4× 2.0k 0.8× 2.5k 1.1× 1.5k 0.7× 145 9.9k
Andrea Ferrari 7.2k 1.3× 2.2k 0.7× 1.3k 0.5× 4.7k 2.0× 2.5k 1.2× 486 14.3k
Carlos Rodríguez‐Galindo 3.7k 0.7× 2.0k 0.7× 1.4k 0.6× 4.1k 1.7× 1.1k 0.5× 356 13.7k
Jeremy Whelan 5.2k 0.9× 1.6k 0.5× 980 0.4× 3.4k 1.4× 1.6k 0.8× 194 9.6k
Mark Krailo 6.8k 1.2× 1.9k 0.6× 2.0k 0.8× 5.7k 2.4× 1.7k 0.8× 392 18.7k
James R. Anderson 7.3k 1.3× 1.3k 0.4× 1.1k 0.4× 4.3k 1.8× 2.1k 1.0× 232 14.4k
Charles B. Pratt 3.7k 0.6× 1.0k 0.3× 1.2k 0.5× 2.8k 1.2× 1.2k 0.6× 198 8.5k
Charles Stiller 2.9k 0.5× 5.5k 1.8× 5.2k 2.1× 3.4k 1.4× 758 0.4× 223 13.9k
Ravi Bhatia 2.1k 0.4× 4.4k 1.5× 4.5k 1.8× 5.9k 2.5× 1.8k 0.9× 463 21.8k

Countries citing papers authored by Holcombe E. Grier

Since Specialization
Citations

This map shows the geographic impact of Holcombe E. Grier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holcombe E. Grier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holcombe E. Grier more than expected).

Fields of papers citing papers by Holcombe E. Grier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holcombe E. Grier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holcombe E. Grier. The network helps show where Holcombe E. Grier may publish in the future.

Co-authorship network of co-authors of Holcombe E. Grier

This figure shows the co-authorship network connecting the top 25 collaborators of Holcombe E. Grier. A scholar is included among the top collaborators of Holcombe E. Grier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holcombe E. Grier. Holcombe E. Grier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cash, Thomas F., Mark Krailo, Allen Buxton, et al.. (2023). Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031. Journal of Clinical Oncology. 41(30). 4724–4728. 6 indexed citations
2.
Campbell, Kevin, David S. Shulman, Holcombe E. Grier, & Steven G. DuBois. (2020). Role of bone marrow biopsy for staging new patients with Ewing sarcoma: A systematic review. Pediatric Blood & Cancer. 68(2). e28807–e28807. 16 indexed citations
3.
Vo, Kieuhoa T., C. Lorrie Epling, Elizabeth Sinclair, et al.. (2016). Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group. Clinical Cancer Research. 22(14). 3643–3650. 17 indexed citations
4.
Schwartz, Cindy L., Leonard H. Wexler, Mark Krailo, et al.. (2015). Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group. Pediatric Blood & Cancer. 63(1). 54–61. 64 indexed citations
5.
Barkauskas, Donald A., Mark Krailo, Sajida Piperdi, et al.. (2014). HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study. Pediatric Blood & Cancer. 61(9). 1558–1564. 17 indexed citations
6.
Womer, Richard B., Daniel C. West, Mark Krailo, et al.. (2012). Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group. Journal of Clinical Oncology. 30(33). 4148–4154. 482 indexed citations breakdown →
7.
Skapek, Stephen X., James R. Anderson, David A. Hill, et al.. (2012). Safety and efficacy of high‐dose tamoxifen and sulindac for desmoid tumor in children: Results of a Children's Oncology Group (COG) Phase II Study. Pediatric Blood & Cancer. 60(7). 1108–1112. 90 indexed citations
8.
Meyers, Paul A., Holcombe E. Grier, Mark L. Bernstein, et al.. (2012). Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children's Oncology Group. Journal of Clinical Oncology. 30(20). 2545–2551. 184 indexed citations
9.
Granowetter, Linda, Richard B. Womer, Meenakshi Devidas, et al.. (2009). Dose-Intensified Compared With Standard Chemotherapy for Nonmetastatic Ewing Sarcoma Family of Tumors: A Children's Oncology Group Study. Journal of Clinical Oncology. 27(15). 2536–2541. 235 indexed citations
10.
DuBois, Steven G. & Holcombe E. Grier. (2009). The role of ifosfamide and etoposide in Ewing sarcoma. Nature Reviews Clinical Oncology. 6(5). 251–253. 6 indexed citations
11.
Meyers, Paul A., Cindy L. Schwartz, Mark Krailo, et al.. (2008). Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group. Journal of Clinical Oncology. 26(4). 633–638. 520 indexed citations breakdown →
12.
Yock, Torunn I., Mark Krailo, Christopher Fryer, et al.. (2006). Local Control in Pelvic Ewing Sarcoma: Analysis From INT-0091—A Report From the Children's Oncology Group. Journal of Clinical Oncology. 24(24). 3838–3843. 100 indexed citations
13.
French, Christopher A., I Miyoshi, Ichiro Kubonishi, et al.. (2003). BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma.. Cancer Research. 63(2). 304–7. 380 indexed citations
14.
Shamberger, Robert C., Michael P. LaQuaglia, Mark C. Gebhardt, et al.. (2003). Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Chest Wall. Annals of Surgery. 238(4). 563–568. 75 indexed citations
15.
Ferguson, William S., Michael B. Harris, Allen M. Goorin, et al.. (2001). Presurgical Window of Carboplatin and Surgery and Multidrug Chemotherapy for the Treatment of Newly Diagnosed Metastatic or Unresectable Osteosarcoma: Pediatric Oncology Group Trial. ˜The œAmerican journal of pediatric hematology/oncology. 23(6). 340–348. 52 indexed citations
16.
McLean, Thomas W., Mary Lynn Young, Karen Marcus, et al.. (1999). Late Events in Pediatric Patients With Ewing Sarcoma/Primitive Neuroectodermal Tumor of Bone. Journal of Pediatric Hematology/Oncology. 21(6). 486–493. 41 indexed citations
17.
Zerbini, Maria Cláudia Nogueira, Simone Treiger Sredni, Holcombe E. Grier, et al.. (1998). Primary Malignant Epithelial Tumors of the Liver in Children: A Study of DNA Content and Oncogene Expression. Pediatric and Developmental Pathology. 1(4). 270–280. 5 indexed citations
18.
Skapek, Stephen X., Fredric A. Hoffer, Gary V. Dahl, et al.. (1998). Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children.. Journal of Clinical Oncology. 16(9). 3021–3027. 105 indexed citations
19.
Tubergen, David G., Clinton F. Stewart, Charles B. Pratt, et al.. (1996). Phase I Trial and Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Topotecan Using a Five-Day Course in Children with Refractory Solid Tumors. Journal of Pediatric Hematology/Oncology. 18(4). 352–361. 112 indexed citations
20.
Collins, John J., Holcombe E. Grier, Navil F. Sethna, Robert T. Wilder, & Charles B. Berde. (1996). Regional anesthesia for pain associated with terminal pediatric malignancy. Pain. 65(1). 63–69. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026